AYTU

Aytu Biopharma Inc

2.32

0.15+6.91%

After Hours: 2.300 -0.02 -0.86%16:16 07/16 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.170/2.170

TODAY RANGE2.153-2.370

VOL238.64K

MARKET CAP20.83M

52 WEEK RANGE0.9500-2.870

AVG VOL (3M)1.49M

% TURNOVER2.66%

TURNOVER--

P/E (TTM)-29.0000

% RANGE9.98%

EPS(TTM)-0.0800

P/E(FORWARD)3.515

P/B0.4102

BVPS5.66

DIVIDEND--

P/S0.1711

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP19.06M

SHARES OUTSTANDING8.98M

NEXT EARNINGS09/24-09/29

FREE FLOAT8.21M

LOT SIZE1

EX-DATE01/06/2023

News

Press Releases

Financial Reports

Profile

TipRanks·07/08 17:45
Aytu BioPharma management to meet with Maxim
TipRanks·07/05 09:00
Aytu, Hasbro, Hyatt, Gen Digital, Carrier: Trending by Analysts
Dow Jones·07/01 14:58
Aytu BioPharma Price Target Announced at $8.00/Share by Lake Street
Benzinga·07/01 14:47
Lake Street Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $8
TipRanks·07/01 13:06
Aytu BioScience (AYTU) Receives a Buy from Lake Street
TipRanks·07/01 12:55
Aytu BioPharma initiated with a Buy at Lake Street
TipRanks·06/30 17:30
Analysts Offer Insights on Healthcare Companies: Aytu BioScience (AYTU), Processa Pharmaceuticals (PCSA) and Clene (CLNN)
Benzinga·06/30 17:04
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Dow Jones·06/30 10:44
Aytu BioPharma Price Target Announced at $12.00/Share by Ascendiant Capital
Dow Jones·06/30 10:44
Aytu BioPharma Initiated at Buy by Ascendiant Capital
Benzinga·06/30 10:34
Ascendiant Capital Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $12
TipRanks·06/30 09:20
Aytu BioPharma initiated with a Buy at Ascendiant
TipRanks·06/25 12:30
Aytu BioPharma appoints Gerwin Westfield as SVP, scientific affairs
TipRanks·06/23 18:43
Aytu BioScience Expands Lending Agreement for EXXUA Launch
TipRanks·06/23 17:53
Aytu BioPharma expands, extends lending agreement with Eclipse

Same Industry

Name/Symbol

Change%

Price

Aytu Biopharma Inc

AYTU

+6.91%

2.32

McKesson

MCK

+0.69%

715.74

Biogen Inc

BIIB

+0.75%

128.46

Amgen Inc

AMGN

+2.23%

299.02

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-0.29%

0.0344

Lilly Eli & Co

LLY

+2.34%

789.80

Celgene

CELG

108.24

Therapeuticsmd Inc

TXMD

+1.32%

1.15

Johnson & Johnson

JNJ

+6.19%

164.78

Abbvie Inc

ABBV

+2.25%

190.58

Zoetis Inc

ZTS

-0.86%

151.54

Gilead Sciences Inc

GILD

+0.72%

109.85

Novo-Nordisk A/S

NVO

-0.27%

67.04

Bristol-Myers Squibb Co

BMY

+1.59%

47.17

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

0.00%

24.61

Sanofi FR

SNY

+0.83%

48.52

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.09%

118.37

Dr Reddys Labs

RDY

+0.55%

14.61